Clinical Trial Update: The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (EXER-MED) is evaluating whether adding tirzepatide to an exercise program improves weight loss and health outcomes in adults with obes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: University of Virginia | Conditions: Obesity & Overweight | Phase 3 | Status: NOT_YET_RECRUITING